| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9697 |
| Human Intestinal Absorption | HIA+ | 0.9902 |
| Caco-2 Permeability | Caco2+ | 0.8644 |
| P-glycoprotein Substrate | Non-substrate | 0.6504 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9152 |
| Non-inhibitor | 0.9773 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6237 |
| Distribution |
| Subcellular localization | Lysosome | 0.6182 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7629 |
| CYP450 2D6 Substrate | Substrate | 0.6203 |
| CYP450 3A4 Substrate | Non-substrate | 0.5147 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6871 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9676 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8150 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9392 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9689 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9567 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9292 |
| Non-inhibitor | 0.8421 |
| AMES Toxicity | Non AMES toxic | 0.8994 |
| Carcinogens | Non-carcinogens | 0.5346 |
| Fish Toxicity | High FHMT | 0.9044 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6226 |
| Honey Bee Toxicity | Low HBT | 0.5384 |
| Biodegradation | Not ready biodegradable | 0.9215 |
| Acute Oral Toxicity | II | 0.8110 |
| Carcinogenicity (Three-class) | Non-required | 0.6162 |